Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 11, 2019 07:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Collaboration and Royalty Agreement With Richmond Cannabis Co.

TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. ("Revive" or the "Company") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development...
February 28, 2019 20:30 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Results for the Three and Six Months Ended December 31, 2018

TORONTO, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) (‘Revive’ or the ‘Company’), a specialty cannabis company focused on the research,...
February 11, 2019 07:00 ET | Source: Revive Therapeutics Ltd.

Revive Closes Over 1.4 Million in Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 11, 2019 (GLOBE NEWSWIRE) --...
February 05, 2019 07:00 ET | Source: Revive Therapeutics Ltd.

Revive Announces Closing of the First Tranche of Its Non-Brokered Private Placement for Total Gross Proceeds of Over $1 Million

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) --...
January 23, 2019 16:00 ET | Source: Revive Therapeutics Ltd.

Revive Provides an Update on the Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Jan. 23, 2019 (GLOBE NEWSWIRE)...
December 07, 2018 17:03 ET | Source: Revive Therapeutics Ltd.

Revive Announces a $2 Million Non-Brokered Private Placement

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Dec. 07, 2018 (GLOBE NEWSWIRE) --...
November 28, 2018 22:30 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces Results for the Three Months Ended September 30, 2018

TORONTO, Nov. 28, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research,...
November 07, 2018 08:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Announces FDA Grants Orphan Drug Designation for Cannabidiol in the Prevention of Ischemia and Reperfusion Injury from Organ Transplantation

TORONTO, Nov. 07, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE:31R) ("Revive" or the “Company”), a specialty cannabis company focused on the research,...
October 26, 2018 18:30 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Ltd. Announces Results for Fiscal Year Ended June 30, 2018

TORONTO, Oct. 26, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research,...
September 11, 2018 07:00 ET | Source: Revive Therapeutics Ltd.

Revive Therapeutics Introduces RELICANN™ a New Brand for Hemp-based CBD Wellness and Medical Cannabis Market

TORONTO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (TSX VENTURE: RVV) (OTCQB: RVVTF) (FSE: 31R) (“Revive” or the “Company”), a specialty cannabis company focused on the research,...